Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pivotal mental states
Ari Brouwer, Robin Carhart‐Harris
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 319-352
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart‐Harris, Bruna Giribaldi, Rosalind Watts, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 15, pp. 1402-1411
Open Access | Times Cited: 982
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173
Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects
Jacob S. Aday, Alan K. Davis, Cayla M. Mitzkovitz, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 424-435
Open Access | Times Cited: 167
Psychedelics alter metaphysical beliefs
Christopher Timmermann, Hannes Kettner, Chris Letheby, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 126
Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
Joseph Peill, Katie Trinci, Hannes Kettner, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 1, pp. 31-45
Open Access | Times Cited: 100
A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics
Christopher Timmermann, Prisca R. Bauer, Olivia Gosseries, et al.
Trends in Cognitive Sciences (2022) Vol. 27, Iss. 2, pp. 139-159
Open Access | Times Cited: 73
Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications
Francesco Weiss, Anna Magnesa, Matteo Gambini, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 117-117
Open Access | Times Cited: 3
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Richard J. Zeifman, Meg J. Spriggs, Hannes Kettner, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Rita Kočárová, Jiřı́ Horáček, Robin Carhart‐Harris
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 65
Canalization and plasticity in psychopathology
Robin Carhart‐Harris, Shamil Chandaria, David Erritzøe, et al.
Neuropharmacology (2022) Vol. 226, pp. 109398-109398
Open Access | Times Cited: 64
Perspectives for therapy of treatment‐resistant depression
Mariusz Papp, Wiesław Jerzy Cubała, Łukasz Świȩcicki, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4181-4200
Open Access | Times Cited: 60
Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
Meg J. Spriggs, Hannah Douglass, Rebecca J. Park, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 59
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States
Charles L. Raison, Rakesh K. Jain, Andrew Penn, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 45
Understanding the effects of serotonin in the brain through its role in the gastrointestinal tract
James M. Shine, Claire O’Callaghan, Ishan C. Walpola, et al.
Brain (2022) Vol. 145, Iss. 9, pp. 2967-2981
Closed Access | Times Cited: 42
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility
Max Wolff, Lea J. Mertens, Marie Walter, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 387-408
Open Access | Times Cited: 37
Defining Transformative Experiences: A Conceptual Analysis
Alice Chirico, Marta Pizzolante, Alexandra Kitson, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 37
Pattern breaking: a complex systems approach to psychedelic medicine
Inês Hipólito, Jonas Mago, Fernando E. Rosas, et al.
Neuroscience of Consciousness (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 37
Transformative experience and informed consent to psychedelic-assisted psychotherapy
Edward Jacobs
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 28
Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics
Kadi Tulver, Karl Kristjan Kaup, Ruben Laukkonen, et al.
Consciousness and Cognition (2023) Vol. 110, pp. 103494-103494
Open Access | Times Cited: 27
Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice
N. Jones, Zarmeen Zahid, Sean M. Grady, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 8, pp. 1221-1231
Open Access | Times Cited: 26
Psychedelics and the ‘inner healer’: Myth or mechanism?
Joseph Peill, M. Marguilho, David Erritzøe, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 417-424
Open Access | Times Cited: 7
Psychedelics, Sociality, and Human Evolution
José Manuel Rodríguez Arce, Michael Winkelman
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 49
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
Emma I Kopra, Jason Ferris, James Rucker, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 956-964
Open Access | Times Cited: 31
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
Edward James, Joachim Keppler, Thomas L Robertshaw, et al.
Human Psychopharmacology Clinical and Experimental (2022) Vol. 37, Iss. 3
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top